Benchmarks for antiretroviral therapy

被引：7

作者：

Cohen, OJ

Fauci, AS

机构：

[1] NIAID, Bethesda, MD 20892 USA

[2] Dept Hlth & Human Serv, Henry J Kaiser Family Fdn Panel Clin Practices Tr, Washington, DC USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 105卷 / 06期

关键词：

D O I：

10.1172/JCI9590

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：709 / 710

页数：2

相关论文

共 25 条

[21] Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy
Raboud, JM
Montaner, JSG
Conway, B
Rae, S
Reiss, P
Vella, S
Cooper, D
Lange, O
Harris, M
Wainberg, MA
Robinson, P
Myers, M
Hall, D
[J]. AIDS, 1998, 12 (13) : 1619 - 1624
[22] Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA
Rizzardi, GP
De Boer, RJ
Hoover, S
Tambussi, G
Chapuis, A
Halkic, N
Bart, PA
Miller, V
Staszewski, S
Notermans, DW
Perrin, L
Fox, CH
Lange, JMA
Lazzarin, A
Pantaleo, G
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) : 777 - 782
[23] Virological response to protease inhibitor therapy in an HIV clinic cohort
Staszewski, S
Miller, V
Sabin, C
Carlebach, A
Berger, AM
Weidmann, E
Helm, EB
Hill, A
Phillips, A
[J]. AIDS, 1999, 13 (03) : 367 - 373
[24] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
WEI, XP
GHOSH, SK
TAYLOR, ME
JOHNSON, VA
EMINI, EA
DEUTSCH, P
LIFSON, JD
BONHOEFFER, S
NOWAK, MA
HAHN, BH
SAAG, MS
SHAW, GM
[J]. NATURE, 1995, 373 (6510) : 117 - 122
[25] Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
Zhang, LQ
Ramratnam, B
Tenner-Racz, K
He, YX
Vesanen, M
Lewin, S
Talal, A
Racz, P
Perelson, AS
Korber, BT
Markowitz, M
Ho, DD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) : 1605 - 1613